|
|
|
|
CasodexScience Daily (press release) AstraZeneca's Casodex may get boost (December 8, 2005) -- A new analysis of the Early Prostate Cancer trial may restore physician confidence in AstraZeneca's ... AstraZeneca Agrees to Pay $210 Million to Buy KuDOS (Update2) Dec 23, 2005 Bloomberg The company's best-selling oncology drug was Casodex, which has been approved to treat prostate cancer. The drug generated about $1 billion in sales. ... AstraZeneca set to acquire first brand soon Dec 14, 2005 Sify, The weeks-old entrants are Casodex for prostate cancer and Iressa for lung cancer, which means five of the parent company's seven oncology brands have now come ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |